Can intranasal corticosteroids be used in an adult with a septal perforation who has no active infection or recent nasal surgery?

Intranasal Corticosteroids Should Generally Be Avoided in Patients with Existing Septal Perforation

Intranasal corticosteroids are contraindicated or should be used with extreme caution in patients with an existing septal perforation, as these medications can cause or worsen septal perforations and impair healing of existing defects. 1

Key Clinical Reasoning

The evidence clearly establishes that:

• Nasal septal perforation is a recognized complication of intranasal corticosteroid use, though rare 1. The mechanism involves repetitive direct application causing local mucosal injury and impaired healing 1.

• Guidelines explicitly recommend periodic nasal septum examination to detect mucosal erosions, which precede perforation development 1. The presence of an existing perforation represents the endpoint of this pathological process.

• Proper administration technique requires directing spray away from the septum 1. With an existing perforation, this protective technique becomes impossible to execute effectively, as the perforation itself represents compromised septal tissue.

Clinical Algorithm for Decision-Making

If septal perforation is present:

1. Discontinue intranasal corticosteroids immediately - The risk of enlarging the perforation or preventing healing outweighs potential benefits

2. Consider alternative therapies:

   • Oral antihistamines (second-generation preferred for safety) 2
   • Intranasal antihistamines (azelastine) - may be safer as they lack the tissue-damaging effects of corticosteroids 1
   • Intranasal cromolyn - though less effective, has no association with septal complications 1
   • Oral leukotriene receptor antagonists (montelukast) 2
   • Saline irrigation alone for symptom relief 3

3. For severe symptoms requiring corticosteroid therapy:

   • Short course (5-7 days) of oral corticosteroids may be appropriate 1
   • Never use intramuscular/parenteral corticosteroids - these are contraindicated due to prolonged systemic effects 1, 2

Important Caveats

Risk factors for perforation development include young age (especially women), first 12 months of treatment, and improper spray technique 4. While your patient may not have these risk factors for developing a perforation, they already have one, making continued use particularly hazardous.

The perforation itself may enlarge with continued intranasal corticosteroid use, as the medication impairs mucosal healing and causes ongoing local tissue damage 4, 5.

Surgical repair considerations: If the patient requires septal perforation repair, intranasal corticosteroids would interfere with healing. Large perforations (≥20mm) have closure rates of 84.4% with surgery 6, but this requires optimal healing conditions.

Quality of Life Considerations

While intranasal corticosteroids are the most effective medication class for allergic rhinitis symptoms 1, 2, 7, using them in a patient with existing septal perforation prioritizes short-term symptom control over preventing permanent structural damage and worsening quality of life from an enlarging perforation (which causes whistling, crusting, bleeding, and nasal obstruction).

The presence of septal perforation fundamentally changes the risk-benefit calculation - what is normally first-line therapy becomes contraindicated due to the existing structural compromise.